Selected research
Market Analysis & Forecast
Global Animal Pharmaceutical Market Analysis and Forecast 2026-2032
Market perspective
The global Animal Pharmaceutical market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Animal Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Animal Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Animal Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Animal Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Animal Pharmaceutical include Merck, Zoetis, Virbac, Vétoquinol, Ringpu Biology, PARNELL, MSD Animal Health Australia, Merial and Jurox, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Animal Pharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Animal Pharmaceutical, also provides the sales of main regions and countries. Of the upcoming market potential for Animal Pharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Animal Pharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Animal Pharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Animal Pharmaceutical sales, projected growth trends, production technology, application and end-user industry.
Animal Pharmaceutical Segment by Company
Merck
Zoetis
Virbac
Vétoquinol
Ringpu Biology
PARNELL
MSD Animal Health Australia
Merial
Jurox
Elanco
Ceva Sante Animale
CAHIC
Boehringer Ingelheim Vetmedica
Bayer Animal Health
Animal Pharmaceutical Segment by Type
Vaccine
Veterinary Drugs
Other
Animal Pharmaceutical Segment by Application
Companion Animal
Poultry
Other
Animal Pharmaceutical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Animal Pharmaceutical in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Animal Pharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Pharmaceutical sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vaccine
- Veterinary Drugs
- Other
Applications
- Companion Animal
- Poultry
- Other
Companies covered
- Merck
- Zoetis
- Virbac
- Vétoquinol
- Ringpu Biology
- PARNELL
- MSD Animal Health Australia
- Merial
- Jurox
- Elanco
- Ceva Sante Animale
- CAHIC
- Boehringer Ingelheim Vetmedica
- Bayer Animal Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Animal Pharmaceutical Market by Type
- 1.2.1 Global Animal Pharmaceutical Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Vaccine
- 1.2.3 Veterinary Drugs
- 1.2.4 Other
- 1.3 Animal Pharmaceutical Market by Application
- 1.3.1 Global Animal Pharmaceutical Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Companion Animal
- 1.3.3 Poultry
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Animal Pharmaceutical Market Dynamics
- 2.1 Animal Pharmaceutical Industry Trends
- 2.2 Animal Pharmaceutical Industry Drivers
- 2.3 Animal Pharmaceutical Industry Opportunities and Challenges
- 2.4 Animal Pharmaceutical Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Animal Pharmaceutical Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Animal Pharmaceutical Revenue by Region
- 3.2.1 Global Animal Pharmaceutical Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Animal Pharmaceutical Revenue by Region (2021-2026)
- 3.2.3 Global Animal Pharmaceutical Revenue by Region (2027-2032)
- 3.2.4 Global Animal Pharmaceutical Revenue Market Share by Region (2021-2032)
- 3.3 Global Animal Pharmaceutical Sales Estimates and Forecasts 2021-2032
- 3.4 Global Animal Pharmaceutical Sales by Region
- 3.4.1 Global Animal Pharmaceutical Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Animal Pharmaceutical Sales by Region (2021-2026)
- 3.4.3 Global Animal Pharmaceutical Sales by Region (2027-2032)
- 3.4.4 Global Animal Pharmaceutical Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Animal Pharmaceutical Revenue by Manufacturers
- 4.1.1 Global Animal Pharmaceutical Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Animal Pharmaceutical Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Animal Pharmaceutical Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Animal Pharmaceutical Sales by Manufacturers
- 4.2.1 Global Animal Pharmaceutical Sales by Manufacturers (2021-2026)
- 4.2.2 Global Animal Pharmaceutical Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Animal Pharmaceutical Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Animal Pharmaceutical Sales Price by Manufacturers (2021-2026)
- 4.4 Global Animal Pharmaceutical Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Animal Pharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Animal Pharmaceutical Manufacturers, Product Type & Application
- 4.7 Global Animal Pharmaceutical Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Animal Pharmaceutical Market CR5 and HHI
- 4.8.2 2025 Animal Pharmaceutical Tier 1, Tier 2, and Tier 3
5 Animal Pharmaceutical Market by Type
- 5.1 Global Animal Pharmaceutical Revenue by Type
- 5.1.1 Global Animal Pharmaceutical Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Animal Pharmaceutical Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Animal Pharmaceutical Revenue Market Share by Type (2021-2032)
- 5.2 Global Animal Pharmaceutical Sales by Type
- 5.2.1 Global Animal Pharmaceutical Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Animal Pharmaceutical Sales by Type (2021-2032) & (Tons)
- 5.2.3 Global Animal Pharmaceutical Sales Market Share by Type (2021-2032)
- 5.3 Global Animal Pharmaceutical Price by Type
6 Animal Pharmaceutical Market by Application
- 6.1 Global Animal Pharmaceutical Revenue by Application
- 6.1.1 Global Animal Pharmaceutical Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Animal Pharmaceutical Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Animal Pharmaceutical Revenue Market Share by Application (2021-2032)
- 6.2 Global Animal Pharmaceutical Sales by Application
- 6.2.1 Global Animal Pharmaceutical Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Animal Pharmaceutical Sales by Application (2021-2032) & (Tons)
- 6.2.3 Global Animal Pharmaceutical Sales Market Share by Application (2021-2032)
- 6.3 Global Animal Pharmaceutical Price by Application
7 Company Profiles
- 7.1 Merck
- 7.1.1 Merck Company Information
- 7.1.2 Merck Business Overview
- 7.1.3 Merck Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Merck Animal Pharmaceutical Product Portfolio
- 7.1.5 Merck Recent Developments
- 7.2 Zoetis
- 7.2.1 Zoetis Company Information
- 7.2.2 Zoetis Business Overview
- 7.2.3 Zoetis Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Zoetis Animal Pharmaceutical Product Portfolio
- 7.2.5 Zoetis Recent Developments
- 7.3 Virbac
- 7.3.1 Virbac Company Information
- 7.3.2 Virbac Business Overview
- 7.3.3 Virbac Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Virbac Animal Pharmaceutical Product Portfolio
- 7.3.5 Virbac Recent Developments
- 7.4 Vétoquinol
- 7.4.1 Vétoquinol Company Information
- 7.4.2 Vétoquinol Business Overview
- 7.4.3 Vétoquinol Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Vétoquinol Animal Pharmaceutical Product Portfolio
- 7.4.5 Vétoquinol Recent Developments
- 7.5 Ringpu Biology
- 7.5.1 Ringpu Biology Company Information
- 7.5.2 Ringpu Biology Business Overview
- 7.5.3 Ringpu Biology Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Ringpu Biology Animal Pharmaceutical Product Portfolio
- 7.5.5 Ringpu Biology Recent Developments
- 7.6 PARNELL
- 7.6.1 PARNELL Company Information
- 7.6.2 PARNELL Business Overview
- 7.6.3 PARNELL Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 PARNELL Animal Pharmaceutical Product Portfolio
- 7.6.5 PARNELL Recent Developments
- 7.7 MSD Animal Health Australia
- 7.7.1 MSD Animal Health Australia Company Information
- 7.7.2 MSD Animal Health Australia Business Overview
- 7.7.3 MSD Animal Health Australia Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 MSD Animal Health Australia Animal Pharmaceutical Product Portfolio
- 7.7.5 MSD Animal Health Australia Recent Developments
- 7.8 Merial
- 7.8.1 Merial Company Information
- 7.8.2 Merial Business Overview
- 7.8.3 Merial Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Merial Animal Pharmaceutical Product Portfolio
- 7.8.5 Merial Recent Developments
- 7.9 Jurox
- 7.9.1 Jurox Company Information
- 7.9.2 Jurox Business Overview
- 7.9.3 Jurox Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Jurox Animal Pharmaceutical Product Portfolio
- 7.9.5 Jurox Recent Developments
- 7.10 Elanco
- 7.10.1 Elanco Company Information
- 7.10.2 Elanco Business Overview
- 7.10.3 Elanco Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Elanco Animal Pharmaceutical Product Portfolio
- 7.10.5 Elanco Recent Developments
- 7.11 Ceva Sante Animale
- 7.11.1 Ceva Sante Animale Company Information
- 7.11.2 Ceva Sante Animale Business Overview
- 7.11.3 Ceva Sante Animale Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Ceva Sante Animale Animal Pharmaceutical Product Portfolio
- 7.11.5 Ceva Sante Animale Recent Developments
- 7.12 CAHIC
- 7.12.1 CAHIC Company Information
- 7.12.2 CAHIC Business Overview
- 7.12.3 CAHIC Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 CAHIC Animal Pharmaceutical Product Portfolio
- 7.12.5 CAHIC Recent Developments
- 7.13 Boehringer Ingelheim Vetmedica
- 7.13.1 Boehringer Ingelheim Vetmedica Company Information
- 7.13.2 Boehringer Ingelheim Vetmedica Business Overview
- 7.13.3 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product Portfolio
- 7.13.5 Boehringer Ingelheim Vetmedica Recent Developments
- 7.14 Bayer Animal Health
- 7.14.1 Bayer Animal Health Company Information
- 7.14.2 Bayer Animal Health Business Overview
- 7.14.3 Bayer Animal Health Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Bayer Animal Health Animal Pharmaceutical Product Portfolio
- 7.14.5 Bayer Animal Health Recent Developments
8 North America
- 8.1 North America Animal Pharmaceutical Market Size by Type
- 8.1.1 North America Animal Pharmaceutical Revenue by Type (2021-2032)
- 8.1.2 North America Animal Pharmaceutical Sales by Type (2021-2032)
- 8.1.3 North America Animal Pharmaceutical Price by Type (2021-2032)
- 8.2 North America Animal Pharmaceutical Market Size by Application
- 8.2.1 North America Animal Pharmaceutical Revenue by Application (2021-2032)
- 8.2.2 North America Animal Pharmaceutical Sales by Application (2021-2032)
- 8.2.3 North America Animal Pharmaceutical Price by Application (2021-2032)
- 8.3 North America Animal Pharmaceutical Market Size by Country
- 8.3.1 North America Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Animal Pharmaceutical Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Animal Pharmaceutical Market Size by Type
- 9.1.1 Europe Animal Pharmaceutical Revenue by Type (2021-2032)
- 9.1.2 Europe Animal Pharmaceutical Sales by Type (2021-2032)
- 9.1.3 Europe Animal Pharmaceutical Price by Type (2021-2032)
- 9.2 Europe Animal Pharmaceutical Market Size by Application
- 9.2.1 Europe Animal Pharmaceutical Revenue by Application (2021-2032)
- 9.2.2 Europe Animal Pharmaceutical Sales by Application (2021-2032)
- 9.2.3 Europe Animal Pharmaceutical Price by Application (2021-2032)
- 9.3 Europe Animal Pharmaceutical Market Size by Country
- 9.3.1 Europe Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Animal Pharmaceutical Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Animal Pharmaceutical Market Size by Type
- 10.1.1 China Animal Pharmaceutical Revenue by Type (2021-2032)
- 10.1.2 China Animal Pharmaceutical Sales by Type (2021-2032)
- 10.1.3 China Animal Pharmaceutical Price by Type (2021-2032)
- 10.2 China Animal Pharmaceutical Market Size by Application
- 10.2.1 China Animal Pharmaceutical Revenue by Application (2021-2032)
- 10.2.2 China Animal Pharmaceutical Sales by Application (2021-2032)
- 10.2.3 China Animal Pharmaceutical Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Animal Pharmaceutical Market Size by Type
- 11.1.1 Asia Animal Pharmaceutical Revenue by Type (2021-2032)
- 11.1.2 Asia Animal Pharmaceutical Sales by Type (2021-2032)
- 11.1.3 Asia Animal Pharmaceutical Price by Type (2021-2032)
- 11.2 Asia Animal Pharmaceutical Market Size by Application
- 11.2.1 Asia Animal Pharmaceutical Revenue by Application (2021-2032)
- 11.2.2 Asia Animal Pharmaceutical Sales by Application (2021-2032)
- 11.2.3 Asia Animal Pharmaceutical Price by Application (2021-2032)
- 11.3 Asia Animal Pharmaceutical Market Size by Country
- 11.3.1 Asia Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Animal Pharmaceutical Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Animal Pharmaceutical Market Size by Type
- 12.1.1 SAMEA Animal Pharmaceutical Revenue by Type (2021-2032)
- 12.1.2 SAMEA Animal Pharmaceutical Sales by Type (2021-2032)
- 12.1.3 SAMEA Animal Pharmaceutical Price by Type (2021-2032)
- 12.2 SAMEA Animal Pharmaceutical Market Size by Application
- 12.2.1 SAMEA Animal Pharmaceutical Revenue by Application (2021-2032)
- 12.2.2 SAMEA Animal Pharmaceutical Sales by Application (2021-2032)
- 12.2.3 SAMEA Animal Pharmaceutical Price by Application (2021-2032)
- 12.3 SAMEA Animal Pharmaceutical Market Size by Country
- 12.3.1 SAMEA Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Animal Pharmaceutical Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Animal Pharmaceutical Value Chain Analysis
- 13.1.1 Animal Pharmaceutical Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Animal Pharmaceutical Production Mode & Process
- 13.2 Animal Pharmaceutical Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Animal Pharmaceutical Distributors
- 13.2.3 Animal Pharmaceutical Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst